The resins for our materials are sourced exclusively from trusted manufacturers. All resins are pre-assessed for biocompatibility in alignment with the intended use of the final product.

We adhere to a robust Management of Change (MoC) protocol with our suppliers and have also implemented MoC processes for our own conversion routes. This way, we are able to safeguard medical requirements at every stage, ensuring consistency across batches and stability in our supply chain.

Although it is common market practice to pre-assess only resins for biocompatibility, this fails to consider how the conversion process (e.g. extrusion, compression molding, injection molding) may impact biological safety.

For our materials, we conduct an additional level of pre-assessment at the stock shape level, certifying that biological safety remains valid throughout the conversion process. The result is that we can certify what we sell, giving you pre-assessment testing data for the semi-finished stock shape that is one step closer to your final component.

Our unique range of processing capabilities for medical grade plastics includes:

• Production of semi-finished stock shapes via extrusion or compression molding
• Production of near net shapes that save materials, machining time, and costs, thereby reducing environmental impact
• Production of injection molded parts
• Machining, cleaning, assembly, and testing of final components
• Cleanroom facilities